Topical Melatonin Unfolds Differential Anti-Aging Effects in Human Skin by Inhibiting mTORC1 Activity via TSC2 Stimulation

    T. Gomez Gomez, K. Linowiecka, M. Hartoyo, F. Dostillio, T. Samra, R. Kassir, Jérémy Chéret, Ralf Paus
    From the encyclopedia
    Rapamycin →

    mTOR regulator and immunosuppressant used more recently for anti-aging and hair regrowth

    Studysummary This study found that topically applied melatonin exerts significant anti-aging effects on human scalp skin ex vivo, including increased SIRT1 expression and reduced mTORC1 pathway activity. Our plain-language summary of this paper — not a Tressless recommendation.
    This study investigates the anti-aging effects of topical melatonin (MT) on aged scalp skin from 3 healthy male donors. When applied at concentrations of 100μM and 1mM for 6 days, MT significantly increased SIRT1 and collagen I expression while reducing matrix metalloprotease 1 in the skin. At 100μM, MT also increased PGC1α expression and reduced mTORC1 pathway activity, similar to rapamycin. Notably, MT prevented the up-regulation of p-S6 and rescued TSC2 downregulation when TSC2 was silenced. These findings highlight MT's potential as a topical anti-aging agent and its novel role in stimulating TSC2, a key inhibitor of mTORC1, offering insights into its diverse functions.
    Discuss this study in the Community →